Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
SMRT
|
Isaiah De Rose Wilson
Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 465 Reduced 0.41% |
$678
$1.46 p/Share
|
Oct 17
2025 |
|
SMRT
|
Isaiah De Rose Wilson
Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 1,111 Added 0.97% |
-
|
Oct 17
2025 |
|
BRT
|
Investors L P Gould |
BUY
Open market or private purchase
|
Direct | 3,953 Added 0.1% |
$59,176
$14.97 p/Share
|
Oct 17
2025 |
|
BRT
|
Matthew J Gould
SENIOR VICE PRESIDENT |
BUY
Open market or private purchase
|
Indirect | 3,953 Added 0.0% |
$59,176
$14.97 p/Share
|
Oct 17
2025 |
|
BRT
|
Jeffrey Gould
PRESIDENT AND CEO |
BUY
Open market or private purchase
|
Indirect | 3,953 Added 0.0% |
$59,176
$14.97 p/Share
|
Oct 17
2025 |
|
MSTR
|
Jarrod M Patten |
BUY
Open market or private purchase
|
Direct | 12,000 Added 29.03% |
$1,162,560
$96.88 p/Share
|
Oct 17
2025 |
|
LECO
|
Gabriel Bruno
EVP, CFO & TREASURER |
SELL
Payment of exercise price or tax liability
|
Direct | 261 Reduced 0.88% |
$61,340
$235.02 p/Share
|
Oct 17
2025 |
|
UTHR
|
Martine A Rothblatt
Chairperson & CEO |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 96.85% |
$1,724,720
$431.18 p/Share
|
Oct 17
2025 |
|
UTHR
|
Martine A Rothblatt
Chairperson & CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 4,000 Added 49.2% |
$481,040
$120.26 p/Share
|
Oct 17
2025 |
|
MBX
|
Steven L. Hoerter |
BUY
Open market or private purchase
|
Indirect | 20,000 Added 0.0% |
$265,000
$13.25 p/Share
|
Oct 17
2025 |
|
PAYO
|
Beatrice Ordonez
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 60,485 Reduced 2.52% |
$345,974
$5.72 p/Share
|
Oct 17
2025 |
|
CRM
|
Marc Benioff
Chair and CEO |
SELL
Open market or private sale
|
Direct | 2,250 Reduced 0.02% |
$554,692
$246.53 p/Share
|
Oct 17
2025 |
|
CRM
|
Marc Benioff
Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 2,250 Added 0.02% |
$363,375
$161.5 p/Share
|
Oct 17
2025 |
|
APDN
|
Clay Shorrock
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 18,691 Added 49.99% |
-
|
Oct 17
2025 |
|
APDN
|
Judith Murrah
Director |
BUY
Grant, award, or other acquisition
|
Direct | 18,691 Added 50.0% |
-
|
Oct 17
2025 |
|
AREC
|
Golden Properties Ltd. |
SELL
Open market or private sale
|
Direct | 980,000 Reduced 7.91% |
$3,978,799
$4.06 p/Share
|
Oct 17
2025 |
|
TENB
|
Barron Anschutz |
SELL
Open market or private sale
|
Direct | 976 Reduced 1.56% |
$28,401
$29.1 p/Share
|
Oct 17
2025 |
|
APDN
|
Yacov A Shamash
Director |
BUY
Grant, award, or other acquisition
|
Direct | 22,511 Added 50.0% |
-
|
Oct 17
2025 |
|
CNS
|
Michael T. Donohue
Interim CFO, SVP |
BUY
Grant, award, or other acquisition
|
Direct | 2,154 Added 7.65% |
-
|
Oct 17
2025 |
|
APDN
|
Elizabeth M. Ferguson
Director |
BUY
Grant, award, or other acquisition
|
Direct | 22,511 Added 50.0% |
-
|
Oct 17
2025 |
|
APDN
|
Beth Jantzen
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 18,691 Added 50.0% |
-
|
Oct 17
2025 |
|
TEAM
|
Michael Cannon Brookes
CEO, Co-Founder |
SELL
Open market or private sale
|
Indirect | 7,665 Reduced 0.0% |
$1,156,801
$150.92 p/Share
|
Oct 17
2025 |
|
APDN
|
Robert B Catell
Director |
BUY
Grant, award, or other acquisition
|
Direct | 22,511 Added 50.0% |
-
|
Oct 17
2025 |
|
TEAM
|
Scott Farquhar |
SELL
Open market or private sale
|
Indirect | 7,665 Reduced 0.0% |
$1,156,801
$150.92 p/Share
|
Oct 17
2025 |
|
APDN
|
Joseph D. Ceccoli
Director |
BUY
Grant, award, or other acquisition
|
Direct | 22,511 Added 50.0% |
-
|
Oct 17
2025 |
|
AZO
|
Philip B. Daniele
President & CEO |
SELL
Open market or private sale
|
Direct | 2,533 Reduced 97.91% |
$10,187,295
$4021.83 p/Share
|
Oct 17
2025 |
|
AZO
|
Philip B. Daniele
President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 2,533 Added 49.47% |
$1,487,200
$587.13 p/Share
|
Oct 17
2025 |
|
JBL
|
Mark T Mondello
Executive Chairman |
SELL
Open market or private sale
|
Direct | 40,000 Reduced 3.08% |
$8,317,600
$207.94 p/Share
|
Oct 17
2025 |
|
HWC
|
John M Hairston
President & CEO |
SELL
Open market or private sale
|
Direct | 21,883 Reduced 7.47% |
$1,195,905
$54.65 p/Share
|
Oct 17
2025 |
|
HWC
|
Michael M Achary
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 9,894 Reduced 15.08% |
$542,784
$54.86 p/Share
|
Oct 17
2025 |
|
HIMS
|
Oluyemi Okupe
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 11,592 Reduced 14.17% |
$662,250
$57.13 p/Share
|
Oct 17
2025 |
|
HIMS
|
Oluyemi Okupe
Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 11,592 Added 12.41% |
$95,865
$8.27 p/Share
|
Oct 17
2025 |
|
TPL
|
Horizon Kinetics Asset Management LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 1 Added 0.0% |
$929
$929.17 p/Share
|
Oct 17
2025 |
|
LEG
|
Lindsey Nicole Odaffer
EVP - Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct | 360 Added 0.61% |
$2,635
$7.32 p/Share
|
Oct 17
2025 |
|
LEG
|
Robert S Smith Jr
EVP, Pres. - Spec. and FF&T |
BUY
Grant, award, or other acquisition
|
Direct | 352 Added 0.35% |
$2,576
$7.32 p/Share
|
Oct 17
2025 |
|
LEG
|
Tammy M Trent
SVP - Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct | 176 Added 0.26% |
$1,288
$7.32 p/Share
|
Oct 17
2025 |
|
RCG
|
Murray Stahl
President/Co-Portfolio Manager |
BUY
Open market or private purchase
|
Indirect | 774 Added 0.0% |
$2,027
$2.62 p/Share
|
Oct 17
2025 |
|
RCG
|
Murray Stahl
President/Co-Portfolio Manager |
BUY
Open market or private purchase
|
Direct | 360 Added 0.3% |
$943
$2.62 p/Share
|
Oct 17
2025 |
|
LEG
|
Benjamin Michael Burns
Executive Vice President - CFO |
BUY
Grant, award, or other acquisition
|
Direct | 469 Added 0.33% |
$3,433
$7.32 p/Share
|
Oct 17
2025 |
|
LEG
|
Jennifer Joy Davis
EVP - GENERAL COUNSEL |
BUY
Grant, award, or other acquisition
|
Direct | 248 Added 0.29% |
$1,815
$7.32 p/Share
|
Oct 17
2025 |
|
LEG
|
Karl G Glassman
President and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 316 Added 0.03% |
$2,382
$7.54 p/Share
|
Oct 17
2025 |
|
LEG
|
James Tyson Hagale
EVP, Pres. - Bedding Products |
BUY
Grant, award, or other acquisition
|
Direct | 469 Added 0.33% |
$3,433
$7.32 p/Share
|
Oct 17
2025 |
|
LEG
|
Ryan Michael Kleiboeker
EVP-Chief Strategic Plan. Off. |
BUY
Grant, award, or other acquisition
|
Direct | 321 Added 0.37% |
$2,349
$7.32 p/Share
|
Oct 17
2025 |
|
NTRA
|
Jonathan Sheena |
SELL
Open market or private sale
|
Indirect | 1,500 Reduced 0.0% |
$268,455
$178.97 p/Share
|
Oct 17
2025 |
|
ROIV
|
Eric Venker
President & Immunovant CEO |
SELL
Open market or private sale
|
Direct | 118,418 Reduced 7.29% |
$2,020,211
$17.06 p/Share
|
Oct 17
2025 |
|
ROIV
|
Eric Venker
President & Immunovant CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 118,418 Added 6.8% |
$1,876,925
$15.85 p/Share
|
Oct 17
2025 |
|
CRWV
|
Magnetar Financial LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 244,203 Reduced 0.0% |
$33,844,093
$138.59 p/Share
|
Oct 17
2025 |
|
CRWV
|
Magnetar Financial LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 18,371 Reduced 0.0% |
$2,546,036
$138.59 p/Share
|
Oct 17
2025 |
|
RTVA
|
Fred Aslan
President and CEO |
SELL
Open market or private sale
|
Direct | 25,500 Reduced 6.67% |
$153,000
$6.0 p/Share
|
Oct 17
2025 |
|
WAVD
|
Windsor Private Capital LP |
SELL
Open market or private sale
|
Indirect | 45,036 Reduced 0.0% |
$114,841
$2.55 p/Share
|
Oct 17
2025 |